MoAb A33 shows promise in targeting colon cancer for radioimmunotherapy.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000532:radiotherapy*; D006801:Humans; D051379:Mice; D016499:Radioimmunotherapy
D000911:Antibodies, Monoclonal